ÂÜÀòÂÒÂ×

Youngjoo Kim has extensive experience in the pharmaceutical industry, currently serving as President at Chong Kun Dang Pharm. since March 2015. Prior to this role, Youngjoo was the General Manager of Merck Serono from January 2008 to March 2015, focusing on total business management, improving profitability, organizational development, and market positioning. Additionally, Youngjoo held positions as Marketing Director and Unit Director at Novartis from January 2005 to December 2008 and as Onco Unit Director at Eli Lilly and Company from January 2000 to December 2005. Educational qualifications include a Master's degree in Immunology from LIU in the USA (1986-1989) and a Bachelor of Applied Science in Microbiology from Korea University (1982-1986).